StockData
Zomedica Corp. logo

Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Zomedica's revenue for the twelve months ending Jun 30, 2026 was $36.88M, up 30.1% year over year. For fiscal 2025 it was $32.03M, up 17.4% from the year before. The highest annual figure on record is $32.03M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.03M+17.4%
FY2024Dec 31, 2024$27.29M+8.3%
FY2023Dec 31, 2023$25.19M+33.0%
FY2022Dec 31, 2022$18.93M+358.0%
FY2021Dec 31, 2021$4.13M–
FY2020Dec 31, 2020$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.51M+36.6%
Q1 FY2026Mar 31, 2026$8.80M+35.4%
Q4 FY2025Dec 31, 2025$10.47M+32.6%
Q3 FY2025Sep 30, 2025$8.10M+15.7%
Q2 FY2025Jun 30, 2025$6.96M+13.6%
Q1 FY2025Mar 31, 2025$6.50M+3.8%
Q4 FY2024Dec 31, 2024$7.90M+7.6%
Q3 FY2024Sep 30, 2024$7.00M+10.2%
Q2 FY2024Jun 30, 2024$6.13M+1.8%
Q1 FY2024Mar 31, 2024$6.26M+14.2%
Q4 FY2023Dec 31, 2023$7.34M+19.2%
Q3 FY2023Sep 30, 2023$6.35M+32.9%
Q2 FY2023Jun 30, 2023$6.02M+41.8%
Q1 FY2023Mar 31, 2023$5.48M+46.1%
Q4 FY2022Dec 31, 2022$6.16M+50.9%
Q3 FY2022Sep 30, 2022$4.78M+20665.2%
Q2 FY2022Jun 30, 2022$4.25M+26437.5%
Q1 FY2022Mar 31, 2022$3.75M+26692.9%
Q4 FY2021Dec 31, 2021$4.08M–
Q3 FY2021Sep 30, 2021$23.00K–
Q2 FY2021Jun 30, 2021$16.00K–
Q1 FY2021Mar 31, 2021$14.00K–
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$0–
Q2 FY2020Jun 30, 2020$0–

More Zomedica figures

See a number that looks wrong?